Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Weight Loss 1Neoplasms 1Fatigue 1Anorexia 1

Interventions

Exercise 34Therapeutics 22Modafinil 21Yoga 17Methylphenidate 16Psychiatric Rehabilitation 11Acupuncture Therapy 11Surveys and Questionnaires 10Educational Status 9Walking 8Early Intervention, Educational 8Cognitive Behavioral Therapy 8Ultraviolet Therapy 7Control Groups 7Therapeutic Touch 6Physical Therapy Modalities 6Exercise Therapy 6Acceptance and Commitment Therapy 6Sugars 5Qigong 5Counseling 5Standard of Care 4Saline Solution 4Palliative Care 4Methods 4Epoetin Alfa 4Dexamethasone 4Behavior Therapy 4Acupressure 4methyl hydroxyethyl cellulose 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fatigue × EOM613 × Clear all
NCT01206335 2012-11-27

Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia

Ohr Pharmaceutical Inc.

Phase 2 Unknown
20 enrolled

Anorexia, Fatigue, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡